Arrowhead Pharmaceuticals Corp (ARWR) Tops Q2 EPS by 1c, Miss on Revenues

Arrowhead Pharmaceuticals Corp (NASDAQ: ARWR) reported Q2 EPS of ($0.18), $0.01 better than the analyst estimate of ($0.19). Revenue for the quarter came in at $650 thousand versus the consensus estimate of $1.85 million.

For earnings history and earnings-related data on Arrowhead Pharmaceuticals Corp (ARWR) click here.

You May Also Be Interested In

• Casey's General Stores (CASY) Tops Q1 EPS by 69c
• Citi Starts Arrowhead Pharma (ARWR) at Buy
• Barnes & Noble Education (BNED) Tops Q1 EPS by 12c